Mediware Investor Sues Over $195M Thoma Bravo Tie-Up

Law360, New York (October 18, 2012, 10:21 PM EDT) -- Clinical software provider Mediware Information Systems Inc. was hit with a putative shareholder class action Thursday challenging its proposed $195 million merger with private equity firm Thoma Bravo LLC, saying the deal does not adequately compensate Mediware stockholders.

In a complaint filed in New York state court, shareholder Gordon Kempf accuses Mediware and its executives of failing to adhere to their fiduciary duty by agreeing to an acquisition that would provide shareholders with $22 per share of Mediware common stock, a 40 percent premium over the...
To view the full article, register now.